Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Pfizer’s Arena buyout looks canny, as etrasimod aces phase 3 trials

NICE finds solution to making Keytruda available for TNBC

Dermavant claims its first approval as FDA clears psoriasis drug

Top 5 takeaways from international hybrid and virtual meeting guidance for pharma

Pfizer makes non-profit pledge for low-income nations

sotorasib

Amgen_flag

News/ News/ Oncology

NHS fast tracks access to Amgen’s just-approved KRAS cancer drug

Phil Taylor access, Amgen, KRAS, lung cancer, MHRA, NHS, Oncology, Project Orbis, sotorasib 0 Comment

Amgen’s first-in-class KRAS inhibitor Lumykras has been approved in Great Britain and arrives already armed with an agreement

X

NHS fast tracks access to Amgen’s just-approved KRAS cancer drug

https://pharmaphorum.com/news/nhs-fast-tracks-access-to-amgens-just-approved-kras-cancer-drug/

AmgenLandscape 2

News/ News/ Oncology

Amgen offers hope in KRAS-mutated cancer with sotorasib read-out

Richard Staines Amgen, cancer, lung cancer, sotorasib 0 Comment

Last year Amgen intrigued scientists and investors alike after announcing data showing it had produced the first drug

X

Amgen offers hope in KRAS-mutated cancer with sotorasib read-out

https://pharmaphorum.com/news/amgen-offers-hope-in-kras/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

AbbVie files continuous Parkinson's therapy ABBV-951 in US
Dupixent claims new territory in eosinophilic oesophagitis
Second trial opens door for Lilly's mirikizumab in ulcerative colitis
Monkeypox cases are rising. Should we be worried?
PTC gets green light for gene therapy Upstaza in EU

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com